- Lobbying
- Alec AND Aramanda
Lobbying Arrangements Results for 'Alec Aramanda'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to Medicare coverage of telehealth and health provider supervision flexibilities. Medicare coverage of virtual and in-home cardiac rehabilitation services, including H.R. 1406--Susta... |
Recora
|
Williams and Jensen, PLLC | |||
Details FDA regulatory review and approval issues. |
Dr. Emil Kakkis
|
Williams and Jensen, PLLC | |||
Details Issues of interest to the broad business community, including tax and general matters. Issues of interest to the broad business community, including trade and general matters. |
Business Roundtable
|
Williams and Jensen, PLLC | |||
Details Educate and inform Members about a FDA proposed rule. Reclassification of wound care products and the potential consequences. |
Argentum Medical
Manufacturer of wound care products. |
Williams and Jensen, PLLC | |||
Details Medicare status; support for small community hospitals and rural healthcare. Support for community hospitals and rural healthcare. |
Colorado West Healthcare System, Inc. DBA Community Hospital
|
Williams and Jensen, PLLC | |||
Details H.R. 2407/S.2085, The Medicare Multi-Cancer Early Detection Screening Coverage Act. |
GRAIL, LLC
|
Williams and Jensen, PLLC | |||
Details Work to educate Republican and Democrat Members on the unique model of RRPA for providing psychiatric care and developing potential care pilot programs in Medicaid and/or CMMI. |
River Region Psychiatry Associates
A private physician practice providing psychiatric services. |
Williams and Jensen, PLLC | |||
Details Medicare coverage issue for non-opioid product. |
Rayner
|
Williams and Jensen, PLLC | |||
Details Issues related to drug pricing and reimbursement for prescription drugs related to, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescri... |
BeiGene USA, Inc.
|
Williams and Jensen, PLLC | |||
Details Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health ... |
Wisconsin Physicians Service Insurance Corporation (dba WPS Health Solutions)
|
Williams and Jensen, PLLC | |||
Details Promote and educate Congress Administration and health orgnizations on the value of AvertD and other SOLVD products Promote and educate Congress Administration and health orgnizations on the value ... |
SOLVD Health
|
Williams and Jensen, PLLC | |||
Details Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-... |
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES
|
Williams and Jensen, PLLC | |||
Details Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19. Issues related to artifi... |
iRhythm Technologies
|
Williams and Jensen, PLLC | |||
Details Remote clinical trials, biomedical research & development, issues related to diversity in clinical trials, real world evidence, pandemic preparedness reauthorization. Clinical trials and research. ... |
Syneos Health, Inc.
|
Williams and Jensen, PLLC | |||
Details Pandemic Preparedness Reauthorization - Strategic National Stockpile PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"). Issues relating to F... |
Owens & Minor, Inc.
|
Williams and Jensen, PLLC | |||
Details General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to a... |
Indivior, Inc.
|
Williams and Jensen, PLLC | |||
Details Animal health , issues impacting medicines and vaccines for animals; ADUFA Reauthorization. (H.R. 1418; S. 1844, H.R. 5860). Monitor issues related to general corporate taxation; issues related to ... |
Zoetis
|
Williams and Jensen, PLLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiov... |
AMGEN, Inc.
|
Williams and Jensen, PLLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. General education about federal policies impac... |
Sanofi, U.S.
|
Williams and Jensen, PLLC | |||
Details Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. Matters affecting plasma donation and potential plasma... |
Plasma Protein Therapeutics Association
|
Williams and Jensen, PLLC | |||
Details Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy ben... |
Novo Nordisk Inc.
|
Williams and Jensen, PLLC | |||
Details Drug pricing proposals. Pharmacy Benefit Manager reform proposals. Tax policy impacting health care and pharmaceutical industry. |
MERCK & CO, INC
|
Williams and Jensen, PLLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing propos... |
PhRMA
|
Williams and Jensen, PLLC | |||
Details International and domestic tax issues. General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, an... |
Eli Lilly & Company
|
Williams and Jensen, PLLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug ... |
PFIZER
|
Williams and Jensen, PLLC | |||
Details Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflat... |
Elevance Health, Inc. (formerly reported as Anthem, Inc.)
|
Williams and Jensen, PLLC |